The CCSG senior leadership includes the MD Anderson president and principal investigator. Dr. Ronald A. DePinho, the provost and executive vice president ad interim. Dr. Thomas Buchholz, the vice president for translational research and co-principal investigator. Dr. Robert Bast, the vice president for basic science and associate director for basic science. Dr. Mien-Chie Hung, the vice president for clinical research administration and associate director for clinical research. Dr. Aman Buzdar, the Vice President for Cancer Prevention and associate director for cancer prevention. Dr. Ernest Hawk, and the chair of the Department of Health Disparities Research and associate director for health disparities Dr. David Wetter. This leadership team comprises the CCSG Executive Committee. Dr. DePinho as president of MD Anderson has authority over all aspects of the institution, providing vision and ultimate oversight for all clinical, research, education, and prevention activities. Dr. DePinho also chairs the MD Anderson institutional executive committee providing leadership and strategic direction in support of MD Anderson's mission and vision. Dr. Buchholz provides executive leadership for the development of all research and academic activities. Dr. Bast meets with program leaders, reviews program membership, encourages program activities, promotes multidisciplinary grants, coordinates the physician-scientist and clinician-investigator programs, meets with shared resource directors, reviews capital equipment requests, oversees finances of the core facilities, helps to develop new shared resources, and recommends use of development funds. Dr. Hung is responsible for facilitating all aspects of basic research and strengthening the intraprogrammatic- and interprogrammatic collaborations of the basic science programs. Dr. Buzdar is responsible for clinical research infrastructure, facilitates all aspects of clinical research and ensures that MD Anderson adheres to the highest standards of clinical research compliance with federal regulations. Dr. Hawk provides strategic and tactical direction to the center's work in cancer prevention research, education, and clinical services, and helped to establish the institution's cancer control program to guide policy, educational, and service initiatives oriented toward community needs. Dr. Wetter coordinates efforts to assure minority participation in clinical trials working with other members of the administration to increase the number of minority patients cared for at MD Anderson.
The senior leadership of the CCSG mirrors the senior leadership of the institution as a whole and provides representation across the research spectrum from basic to translational, clinical and population based research.
|Torres, Harrys A; Hosry, Jeff; Mahale, Parag et al. (2018) Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study. Hepatology 67:36-47|
|Parra, Edwin R; Villalobos, Pamela; Behrens, Carmen et al. (2018) Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. J Immunother Cancer 6:48|
|Yin, Guosheng; Chen, Nan; Lee, J Jack (2018) Bayesian Adaptive Randomization and Trial Monitoring with Predictive Probability for Time-to-event Endpoint. Stat Biosci 10:420-438|
|Nong, Jingying; Gong, Yuhua; Guan, Yanfang et al. (2018) Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer. Nat Commun 9:3114|
|Brown, Justin C; Rickels, Michael R; Troxel, Andrea B et al. (2018) Dose-response effects of exercise on insulin among colon cancer survivors. Endocr Relat Cancer 25:11-19|
|Vakil, Erik; Jimenez, Carlos A; Faiz, Saadia A (2018) Pleural effusions in hematologic malignancies and their management with indwelling pleural catheters. Curr Opin Pulm Med 24:384-391|
|Yedururi, Sireesha; Chawla, Sumedha; Amini, Behrang et al. (2018) Tumor thrombus in the large veins draining primary pelvic osteosarcoma on cross sectional imaging. Eur J Radiol 105:49-55|
|Farinholt, Paige; Park, Minjeong; Guo, Ying et al. (2018) A Comparison of the Accuracy of Clinician Prediction of Survival Versus the Palliative Prognostic Index. J Pain Symptom Manage 55:792-797|
|Oh, Sang Cheul; Sohn, Bo Hwa; Cheong, Jae-Ho et al. (2018) Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun 9:1777|
|Yang, Yi; Li, Chia-Wei; Chan, Li-Chuan et al. (2018) Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res 28:862-864|
Showing the most recent 10 out of 12418 publications